Mirae Asset Global Investments’s Agilon Health AGL Stock Holding History

Mirae Asset Global Investments’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-719	Closed	-$490K	–	1551
2024 Q1	$490K	Buy	719 +66	+10%	+$11K	﹤0.01%	1910
2023 Q4	$205K	Buy	653 +35	+6%	+$12.7K	﹤0.01%	2330
2023 Q3	$274K	Buy	618 +94	+18%	+$42.5K	﹤0.01%	2168
2023 Q2	$227K	Sell	524 -195	-27%	-$110K	﹤0.01%	2294
2023 Q1	$427K	Buy	719 +234	+48%	+$131K	﹤0.01%	2004
2022 Q4	$196K	Buy	485 +12	+3%	+$5.63K	﹤0.01%	2310
2022 Q3	$277K	Sell	473 -117	-20%	-$70.1K	﹤0.01%	2201
2022 Q2	$322K	Buy	+590	New	+$298K	﹤0.01%	1956

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirae Asset Global Investments's AGL Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Agilon Health (AGL) in Q2 2024, closing a stake of 719 shares — an estimated $490K sold.

Mirae Asset Global Investments first reported a position in AGL in Q2 2022 and held it in 8 quarters. The position peaked at $490K in Q1 2024. 201 funds tracked by Wall St. Rank hold AGL as of Q2 2024.

Mirae Asset Global Investments reported no remaining Agilon Health position as of Q2 2024 after selling out during the quarter.
Mirae Asset Global Investments sold 719 Agilon Health shares in Q2 2024, an estimated $490K.
Mirae Asset Global Investments first reported a position in Agilon Health in Q2 2022 and held it in 8 quarters.
Mirae Asset Global Investments's Agilon Health position peaked at $490K in Q1 2024.
201 funds tracked by Wall St. Rank held Agilon Health as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.